Skip to main content
OpenTrials
Completed

NCT Number: NCT02968888

Anabolic Effects of Whey and Casein After Strength Training in Young and Elderly

The aim of this study is to investigate the acute anabolic effects of native whey, whey protein concentrate 80 (WPC-80) and milk after a bout of strength training in young and elderly. The investigators hypothesize that native whey will give a greater stimulation of muscle protein synthesis and intracellular anabolic signaling than WPC-80, and that WPC-80 will give a stronger stimulus than milk.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Norwegian School of Sport Sciences

Oslo, 0863, Norway

About this study

Increasing or maintaining muscle mass is of great importance for populations ranging from athletes to patients and elderly. Resistance exercise and protein ingestion are two of the most potent stimulators of muscle protein synthesis. Both the physical characteristic of proteins (e.g. different digestion rates of whey and casein) and the amino acid composition, affects the potential of a certain protein to stimulate muscle protein synthesis. Given its superior ability to rapidly increase blood leucine concentrations to high levels, whey is often considered the most potent protein source to stimulate muscle protein synthesis. Native whey protein is produced by filtration of unprocessed milk. Consequently, native whey has different characteristics than WPC-80, which is exposed to heating and acidification. Because of the direct filtration of unprocessed milk, native whey is a more intact protein compared with WPC-80. Of special interest is the higher amounts of the highly anabolic amino acid leucine in native whey.

The higher levels of leucine can be of great interest for elderly individuals as some studies in elderly has shown an anabolic resistance to the effects of protein feeding and strength training. By increasing levels of leucine one might overcome this anabolic resistance in the elderly.

The aim of this double-blinded, randomized, partial cross-over study is to compare the acute fractional protein synthesis and intracellular signaling response to a bout of strength training and intake of 20 grams of protein from either native whey, whey protein concentrate 80 or milk, in young and old individuals. Furthermore, the investigators wil investigate fractional protein breakdown, markers of protein breakdown, amino acid concentrations in blood.

The investigators hypothesize that native whey will induce a greater anabolic response than whey protein concentrate 80, and that whey protein concentrate 80 will give a stronger anabolic response than milk.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy in the sense that they can conduct training and testing
  • Able to understand Norwegian language written and oral
  • Between 18 and 45, or above 70 years of age

Exclusion criteria

  • Diseases or injuries contraindicating participation
  • Use of dietary supplements (e.g. proteins, vitamins and creatine)
  • Lactose intolerance
  • Allergy to milk
  • Allergy towards local anesthetics (xylocain)

Treatment and study plan

Strength training

Other

Milk 1%

Dietary Supplement

Whey protein concentrate 80

Dietary Supplement

Native whey

Dietary Supplement

Primary outcomes

  1. Mixed muscle fractional synthetic rate

    Time frame: Three to one hours prior to a bout of strength training and protein consumption

    A continous infusion of a stable isotope (phe D5) is used to measure incorporation of tracer into muscle (biopsies from m. vastus lateralis)

  2. Mixed muscle fractional synthetic rate

    Time frame: One to five hours after a bout of strength training and protein consumption

    A continous infusion of a stable isotope (phe D5) is used to measure incorporation of tracer into muscle (biopsies from m. vastus lateralis)

  3. Mixed muscle fractional synthetic rate

    Time frame: From three to five hours after a bout of strength training and protein consumption

    Two boluses of tracer (phe13C6 and phe15N) was used to measure incorporation of tracer into muscle (biopsies from m. vastus lateralis)

  4. Mixed muscle fractional breakdown rate

    Time frame: From three to five hours after a bout of strength training and protein consumption

    Two boluses of tracer (phe13C6 and phe15N) was used to measure the dilution of tracer in muscle (biopsies from m. vastus lateralis)

Secondary outcomes

  1. Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline

    Time frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake

    Biopsies from m. Vastus Lateralis was analyzed by western blot

  2. Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline

    Time frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake

    Biopsies from m. Vastus Lateralis was analyzed by western blot

  3. Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline

    Time frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake

    Biopsies from m. Vastus Lateralis was analyzed by western blot

  4. Intracellular translocation of forkhead box O3 (FOXO3a) change from baseline

    Time frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake

    Biopsies from m. Vastus Lateralis was analyzed by western blot

  5. Intracellular translocation of muscle RING-finger protein-1 (Murf-1) change from baseline

    Time frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake

    Biopsies from m. Vastus Lateralis was analyzed by western blot

  6. Intracellular translocation of Atrogin1 change from baseline

    Time frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake

    Biopsies from m. Vastus Lateralis was analyzed by western blot

  7. Ubiquitin

    Time frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake

    Biopsies from m. Vastus Lateralis was analyzed by western blot

  8. Plasma amino acid concentration

    Time frame: 180 and 60 min before, and 45, 60, 75, 120, 160, 180, 200, 220 and 300 min after training and protein intake

  9. Muscle force generating capacity change from baseline

    Time frame: 15 min before, 15 and 300 min after, and 24 hours after training and protein intake

    Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.

  10. Plasma glucose

    Time frame: 180 and 60 min before, and 45, 60, 75, 120, 160, 180, 200, 220 and 300 min after training and protein intake

  11. Plasma insulin

    Time frame: 180 and 60 min before, and 45, 60, 75, 120, 160, 180, 200, 220 and 300 min after training and protein intake

  12. Serum urea

    Time frame: 180 and 60 min before, and 60, 10, 180 and 300 min after training and protein intake

  13. Serum ureic acid

    Time frame: 180 and 60 min before, and 60, 10, 180 and 300 min after training and protein intake

  14. Serum creatine kinase

    Time frame: 180 and 60 min before, and 60, 10, 180 and 300 min after training and protein intake

  15. Change in ATP-binding cassette transporter (ABCA1) messenger ribonucleic acid (mRNA)

    Time frame: 1 hour after training and protein intake

  16. Change in ABCA1 mRNA

    Time frame: 5 hous after training and protein intake

  17. Change in BRCA1-A complex subunit Abraxas (ABRA1) mRNA

    Time frame: 1 hour after training and protein intake

  18. Change in ABRA1 mRNA

    Time frame: 5 hours after training and protein intake

  19. Change in alfa-actin (ACTA1) mRNA

    Time frame: 1 hour after training and protein intake

  20. Change in ACTA1 mRNA

    Time frame: 5 hours after training and protein intake

  21. Change in C-C motif chemokine 2 (CCL2) mRNA

    Time frame: 1 hour after training and protein intake

  22. Change in CCL2 mRNA

    Time frame: 5 hours after training and protein intake

  23. Change in C-C motif chemokine 3 (CCL3) mRNA

    Time frame: 1 hour after training and protein intake

  24. Change in CCL3 mRNA

    Time frame: 5 hours after training and protein intake

  25. Change in C-C motif chemokine 5 (CCL5) mRNA

    Time frame: 1 hour after training and protein intake

  26. Change in CCL5 mRNA

    Time frame: 5 hours after training and protein intake

  27. Change in C-C motif chemokine 8 (CCL8) mRNA

    Time frame: 1 hour after training and protein intake

  28. Change in CCL8 mRNA

    Time frame: 5 hours after training and protein intake

  29. Change in platelet glycoprotein 4 (CD36) mRNA

    Time frame: 1 hour after training and protein intake

  30. Change in CD36 mRNA

    Time frame: 5 hours after training and protein intake

  31. Change in cholesterol 25-hydroxylase (CH25H) mRNA

    Time frame: 1 hour after training and protein intake

  32. Change in CH25H mRNA

    Time frame: 5 hours after training and protein intake

  33. Change in granulocyte colony-stimulating factor (CSF3) mRNA

    Time frame: 1 hour after training and protein intake

  34. Change in CSF3 mRNA

    Time frame: 5 hours after training and protein intake

  35. Change in C-X-C motif chemokine 16 (CXCL16) mRNA

    Time frame: 1 hour after training and protein intake

  36. Change in CXCL16 mRNA

    Time frame: 5 hours after training and protein intake

  37. Change in F-box only protein 32 (FBXO32) mRNA

    Time frame: 1 hour after training and protein intake

  38. Change in FBXO32 mRNA

    Time frame: 5 hours after training and protein intake

  39. Change in growth-regulated alpha protein (CXCL1) mRNA

    Time frame: 1 hour after training and protein intake

  40. Change in CXCL1 mRNA

    Time frame: 5 hours after training and protein intake

  41. Change in matrix metalloproteinase-9 (MMP9) mRNA

    Time frame: 1 hour after training and protein intake

  42. Change in MMP9 mRNA

    Time frame: 5 hours after training and protein intake

  43. Change in forkhead box protein O1 (FOXO1) mRNA

    Time frame: 1 hour after training and protein intake

  44. Change in FOXO1 mRNA

    Time frame: 5 hours after training and protein intake

  45. Change in forkhead box protein O3 (FOXO3A) mRNA

    Time frame: 1 hour after training and protein intake

  46. Change in FOXO3A mRNA

    Time frame: 5 hours after training and protein intake

  47. Change in hepatocyte growth factor (HGF) mRNA

    Time frame: 1 hour after training and protein intake

  48. Change in HGF mRNA

    Time frame: 5 hours after training and protein intake

  49. Change in insulin-like growth factor I (IGF1) mRNA

    Time frame: 1 hour after training and protein intake

  50. Change in IGF1 mRNA

    Time frame: 5 hours after training and protein intake

  51. Change in interleukin-10 (IL10) mRNA

    Time frame: 1 hour after training and protein intake

  52. Change in IL10 mRNA

    Time frame: 5 hours after training and protein intake

  53. Change in interleukin-17D (IL17D) mRNA

    Time frame: 1 hour after training and protein intake

  54. Change in IL17D mRNA

    Time frame: 5 hours after training and protein intake

  55. Change in interleukin-1B (IL1B) mRNA

    Time frame: 1 hour after training and protein intake

  56. Change in IL1B mRNA

    Time frame: 5 hours after training and protein intake

  57. Change in interleukin-1 receptor antagonist protein (IL1RN) mRNA

    Time frame: 1 hour after training and protein intake

  58. Change in IL1RN mRNA

    Time frame: 5 hours after training and protein intake

  59. Change in interleukin-6 (IL6) mRNA

    Time frame: 1 hour after training and protein intake

  60. Change in IL6 mRNA

    Time frame: 5 hours after training and protein intake

  61. Change in interleukin-8 (IL8) mRNA

    Time frame: 1 hour after training and protein intake

  62. Change in IL8 mRNA

    Time frame: 5 hours after training and protein intake

  63. Change in transcription factor jun-B (JUNB) mRNA

    Time frame: 1 hour after training and protein intake

  64. Change in JUNB mRNA

    Time frame: 5 hours after training and protein intake

  65. Change in kit ligand (KITLG) mRNA

    Time frame: 1 hour after training and protein intake

  66. Change in KITLG mRNA

    Time frame: 5 hours after training and protein intake

  67. Change in myostatin (MSTN) mRNA

    Time frame: 1 hour after training and protein intake

  68. Change in MSTN mRNA

    Time frame: 5 hours after training and protein intake

  69. Change in myosin-1 (MYH1) mRNA

    Time frame: 1 hour after training and protein intake

  70. Change in MYH1 mRNA

    Time frame: 5 hours after training and protein intake

  71. Change in myosin-2 (MYH2) mRNA

    Time frame: 1 hour after training and protein intake

  72. Change in MYH2 mRNA

    Time frame: 5 hours after training and protein intake

  73. Change in myosin-7 (MYH7) mRNA

    Time frame: 1 hour after training and protein intake

  74. Change in MYH7 mRNA

    Time frame: 5 hours after training and protein intake

  75. Change in oxysterols receptor LXR-alpha (NR1H3) mRNA

    Time frame: 1 hour after training and protein intake

  76. Change in NR1H3 mRNA

    Time frame: 5 hours after training and protein intake

  77. Change in nuclear receptor subfamily 4 group A member 3 (NR4A3) mRNA

    Time frame: 1 hour after training and protein intake

  78. Change in NR4A3 mRNA

    Time frame: 5 hours after training and protein intake

  79. Change in peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) mRNA

    Time frame: 1 hour after training and protein intake

  80. Change in PPARGC1A mRNA

    Time frame: 5 hours after training and protein intake

  81. Change in prostaglandin G/H synthase 2 (PTGS2) mRNA

    Time frame: 1 hour after training and protein intake

  82. Change in PTGS2 mRNA

    Time frame: 5 hours after training and protein intake

  83. Change in proton-coupled amino acid transporter 1 (SLC36A1) mRNA

    Time frame: 1 hour after training and protein intake

  84. Change in SLC36A1 mRNA

    Time frame: 5 hours after training and protein intake

  85. Change in sodium-coupled neutral amino acid transporter 2 (SLC38A2) mRNA

    Time frame: 1 hour after training and protein intake

  86. Change in SLC38A2 mRNA

    Time frame: 5 hours after training and protein intake

  87. Change in 4F2 cell-surface antigen heavy chain (SLC3A2) mRNA

    Time frame: 1 hour after training and protein intake

  88. Change in SLC3A2 mRNA

    Time frame: 5 hours after training and protein intake

  89. Change in large neutral amino acids transporter small subunit 1 (SLC7A5) mRNA

    Time frame: 1 hour after training and protein intake

  90. Change in SLC7A5 mRNA

    Time frame: 5 hours after training and protein intake

  91. Change in toll-like receptor 2 (TLR2) mRNA

    Time frame: 1 hour after training and protein intake

  92. Change in TLR2 mRNA

    Time frame: 5 hours after training and protein intake

  93. Change in tumor necrosis factor (TNF) mRNA

    Time frame: 1 hour after training and protein intake

  94. Change in TNF mRNA

    Time frame: 5 hours after training and protein intake

  95. Change in E3 ubiquitin-protein ligase TRIM63 (TRIM63) mRNA

    Time frame: 1 hour after training and protein intake

  96. Change in E3 ubiquitin-protein ligase TRIM63 (TRIM63) mRNA

    Time frame: 5 hours after training and protein intake

Sponsors and collaborators

Lead sponsor

Norwegian School of Sport Sciences

Other

Collaborators

  • Arkansas Children's Hospital Research Institute
  • The Research Council of Norway
  • Tine

Registry information

Official study title

Effects of Whey and Casein Supplementation on Acute Anabolic Responses in Muscle After Strength Training in Young and Elderly

Important dates

Study start
2014
Primary completion
2015
Study completion
2017
First posted
Nov 21, 2016
Registry last updated
Apr 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.